Microstructural and functional brain abnormalities in multiple sclerosis predicted by osteopontin and neurofilament light

被引:14
|
作者
Orsi, Gergely [1 ,2 ]
Cseh, Tamas [2 ]
Hayden, Zsofia [3 ]
Perlaki, Gabor [1 ,2 ]
Nagy, Szilvia Anett [1 ,2 ]
Giyab, Omar [4 ]
Olsen, Dorte Aalund [5 ]
Madsen, Jonna Skov [5 ,6 ]
Berki, Timea [3 ]
Illes, Zsolt [2 ,7 ,8 ]
机构
[1] Eotvos Lorand Res Network ELKH, MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary
[2] Univ Pecs, Sch Med, Dept Neurol, Pecs, Hungary
[3] Univ Pecs, Sch Med, Dept Immunol & Biotechnol, Pecs, Hungary
[4] Univ Pecs, Sch Med, Dept Med Imaging, Pecs, Hungary
[5] Univ Hosp Southern Denmark, Lillebaelt Hosp, Dept Biochem & Immunol, Vejle, Denmark
[6] Univ Southern Denmark, Dept Reg Hlth Res, Fac Hlth Sci, Odense, Denmark
[7] Odense Univ Hosp, Dept Neurol, JB Winslows Vej 4, DK-5000 Odense, Denmark
[8] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
关键词
Multiple sclerosis; NAWM; Functional connectivity; fMRI; Resting-state; Diffusion; MR spectroscopy; Osteopontin; Neurofilament; DYSFUNCTION; CYTOKINE;
D O I
10.1016/j.msard.2021.102923
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Osteopontin (OPN) is a proinflammatory biomarker, and neurofilament light chain (NFL) levels reflect axonal damage. Resting-state functional MRI (rs-fMRI) defines brain networks during wakeful rest. Objective: To examine, if levels of OPN and NFL are associated on the long term with (i) lesion evolution, (ii) changes in normal-appearing white matter (NAWM) microstructure and (iii) functional connectivity in multiple sclerosis (MS). Methods: Concentration of NFL and OPN in the blood and CSF were related to MRI findings 10.3 +/- 2.8 years later in 53 patients with MS. NFL was examined by Simoa method, OPN by ELISA. Lesion volume in the brain and cervical spinal cord was examined by 3D FLAIR images. Voxel-wise images of fractional anisotropy (FA), axial diffusivity (AD), mean diffusivity (MD), and radial diffusivity (RD) were examined by tract-based spatial statistics corrected for gender, age and lesion volume. Metabolites were examined by single-voxel MR-spectroscopy in the NAWM. Fifty-five default mode network connections were examined by rs-fMRI corrected for gender, age, MS subtype and current therapy as covariates. Results: While NFL in paired serum and CSF positively correlated (p = 0.019), there was no correlation between serum and CSF OPN. Higher OPN levels in the CSF but not in the serum showed association with increased brain WM lesion volume (p = 0.009) in 10.3 +/- 2.8 years. Higher OPN in the CSF was associated with reduced FA, increased MD, and reduced RD in different NAWM areas 10.3 +/- 2.8 years later. Higher OPN in the serum and CSF were associated with increased connectivity strength between the medial prefrontal cortex (MPFC) and other regions except with inferior parietal lobule. NFL in the CSF and in the serum was associated with decreased connectivity strength except for ventral MPFC-hippocampal formation. Neither serum OPN nor NFL at the time of the MRI were associated with functional connectivity changes. Conclusion: While serum NFL levels reflects CNS production, OPN in serum and CSF may have different cellular sources. OPN within the CSF but not in the serum may forecast development of lesions and microstructural abnormalities in 10 years, indicating the detrimental role of CNS inflammation on the long-term. Although both OPN and NFL in the CSF were associated with functional connectivity changes in 10 years, NFL was associated with decreased strength possibly indicating general axonal loss. In contrast, the positive association of OPN levels in the CSF with increased connectivity strength in 10 years may point to adaptive re-organization due to inflammatory WM lesions and microstructural changes.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment
    Rocca, Maria A.
    Valsasina, Paola
    Leavitt, Victoria M.
    Rodegher, Mariaemma
    Radaelli, Marta
    Riccitelli, Gianna C.
    Martinelli, Vittorio
    Martinelli-Boneschi, Filippo
    Falini, Andrea
    Comi, Giancarlo
    Filippi, Massimo
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (04) : 459 - 471
  • [2] The Evolution of Neurofilament Light Chain in Multiple Sclerosis
    Ferreira-Atuesta, Carolina
    Reyes, Saul
    Giovanonni, Gavin
    Gnanapavan, Sharmilee
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [3] Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
    Pukoli, Daniel
    Polyak, Helga
    Rajda, Cecilia
    Vecsei, Laszlo
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [4] Neurofilament light as a prognostic marker in multiple sclerosis
    Salzer, Jonatan
    Svenningsson, Anders
    Sundstrom, Peter
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (03) : 287 - 292
  • [5] High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis
    Buchmann, Arabella
    Pirpamer, Lukas
    Pinter, Daniela
    Voortman, Margarete
    Helmlinger, Birgit
    Pichler, Alexander
    Maceski, Aleksandra Maleska
    Benkert, Pascal
    Bachmaier, Gerhard
    Ropele, Stefan
    Reindl, Markus
    Leppert, David
    Kuhle, Jens
    Enzinger, Christian
    Khalil, Michael
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (05) : 1389 - 1399
  • [6] Brain functional plasticity at rest and during action in multiple sclerosis patients
    Faivre, Anthony
    Rico, Audrey
    Zaaraoui, Wafaa
    Reuter, Francoise
    Confort-Gouny, Sylviane
    Guye, Maxime
    Pelletier, Jean
    Ranjeva, Jean-Philippe
    Audoin, Bertrand
    JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (09) : 1438 - 1443
  • [7] Neurofilament light chain in the assessment of patients with multiple sclerosis
    Domingues, Renan Barros
    Peres Fernandes, Gustavo Bruniera
    Vilela de Moura Leite, Fernando Brunale
    Senne, Carlos
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2019, 77 (06) : 436 - 441
  • [8] NEUROFILAMENT LIGHT CHAIN AS A BIOMARKER FOR DIAGNOSIS OF MULTIPLE SCLEROSIS
    Kouchaki, Ebrahim
    Dashti, Fatemeh
    Mirazimi, Seyed Mohammad Ali
    Alirezaei, Zahra
    Jafari, Seyed Hamed
    Hamblin, Michael R.
    Mirzaei, Hamed
    EXCLI JOURNAL, 2021, 20 : 1308 - 1325
  • [9] Antibodies to neurofilament light as potential biomarkers in multiple sclerosis
    Puentes, Fabiola
    Benkert, Pascal
    Amor, Sandra
    Kuhle, Jens
    Giovannoni, Gavin
    BMJ NEUROLOGY OPEN, 2021, 3 (02)
  • [10] Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis
    Gaetani, Lorenzo
    Salvadori, Nicola
    Lisetti, Viviana
    Eusebi, Paolo
    Mancini, Andrea
    Gentili, Lucia
    Borrelli, Angela
    Portaccio, Emilio
    Sarchielli, Paola
    Blennow, Kaj
    Zetterberg, Henrik
    Parnetti, Lucilla
    Calabresi, Paolo
    Di Filippo, Massimiliano
    JOURNAL OF NEUROLOGY, 2019, 266 (09) : 2157 - 2163